Management Team

Promethera has attracted a leadership team of international experts operating out of R&D and GMP facilities in Mont-Saint-Guibert, Belgium, Durham, NC, USA, Tokyo, Japan and Basel, Switzerland.

Executive Management

John Tchelingerian

PhD, President & CEO

Etienne Sokal

MD, PhD, Chief Scientific & Medical Officer

Mutsuki Takano

Group Chief Financial Officer , Branch General Manager of Promethera Biosciences Japan Branch

Henrik L. Luessen

PhD, Chief Business Officer

Mark Johnston

MBA, CCO Promethera Biosciences Group (Belgium) & Managing Director of Promethera Biosciences LLC (USA)

Bertrand Lellouche

MBA,, CFO EU / US Financial Operations

Nathalie Belmonte

PhD, Chief Operating Officer

Jef Pinxteren

PhD, VP Operations

Paul Smith

VP Regulatory Affairs

Nathalie Clerget

PhD, VP Clinical Development
Sign Up